2,845 reports of this reaction
2.3% of all FLUOROURACIL CREAM, 0.5% reports
#10 most reported adverse reaction
THROMBOCYTOPENIA is the #10 most commonly reported adverse reaction for FLUOROURACIL CREAM, 0.5%, manufactured by Dr. Reddy's Laboratories Inc.. There are 2,845 FDA adverse event reports linking FLUOROURACIL CREAM, 0.5% to THROMBOCYTOPENIA. This represents approximately 2.3% of all 122,970 adverse event reports for this drug.
Patients taking FLUOROURACIL CREAM, 0.5% who experience thrombocytopenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
THROMBOCYTOPENIA is a less commonly reported adverse event for FLUOROURACIL CREAM, 0.5%, but still significant enough to appear in the safety profile.
In addition to thrombocytopenia, the following adverse reactions have been reported for FLUOROURACIL CREAM, 0.5%:
The following drugs have also been linked to thrombocytopenia in FDA adverse event reports:
THROMBOCYTOPENIA has been reported as an adverse event in 2,845 FDA reports for FLUOROURACIL CREAM, 0.5%. This does not prove causation, but indicates an association observed in post-market surveillance data.
THROMBOCYTOPENIA accounts for approximately 2.3% of all adverse event reports for FLUOROURACIL CREAM, 0.5%, making it a notable side effect.
If you experience thrombocytopenia while taking FLUOROURACIL CREAM, 0.5%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.